With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.

With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
A recent study by Assistant Professor Quanyin Hu points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.